U.S FDA Approves AQVESME™ (mitapivat) for Adults with Thalassemia
On December 23, 2025, the U.S. Food and Drug Administration (FDA) approved AQVESME™ (mitapivat) for the treatment…
Read More about U.S FDA Approves AQVESME™ (mitapivat) for Adults with Thalassemia
.png?resize=410x0)
